Extracellular matrix and cardiovascular diseases

Canadian Journal of Cardiology

Volumn 12, Issue 12, 1996, Pages 1259-1267

  Ju, Haisong ^a   Dixon, Ian M C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Angiotensin; Extracellular matrix; Heart failure; Hypertension; Hypertrophy; Myocardial infarction; Restenosis

Indexed keywords

ANGIOTENSIN; COLLAGEN; ELASTIN; FIBRONECTIN; LAMININ; TRANSFORMING GROWTH FACTOR BETA1;

BLOOD VESSEL WALL; EXTRACELLULAR MATRIX; HEART FAILURE; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE FIBROSIS; RESTENOSIS; REVIEW;

ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMEGALY; CARDIOVASCULAR DISEASES; COLLAGEN; ELASTIN; EXTRACELLULAR MATRIX; FIBRONECTINS; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; PROTEOGLYCANS;

EID: 0030445289     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Lin CQ, Bissell MJ. Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 1993;7:737-43.
2. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Cell junction, cell adhesion, and the extracellular matrix. In: Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD, eds. Molecular Biology of the Cell. New York: Garland Publishing, Inc, 1994:972-1000.
3. Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 1989;13:1637-52.
4. Pelouch V, Dixon IMC, Golfman L, Beamish RE, Dhalla NS. Role of extracellular matrix proteins in heart function. Mol Cell Biochem 1993;129:101-20.
5. Weber KT, Sun Y, Tyagi SC, Cleunens JPM. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 1994;26:279-92.
6. Swan HJC. Left ventricular dysfunction in ischemic heart disease: fundamental importance of the fibrous matrix. Cardiovasc Drug Ther 1994;8:305-12.
7. Ju H, Dixon IMC. The cardiac extracellular matrix and its role in the development of heart failure. In: Singal PK, Dixon IMC, Beamish RE, Dhalla NS, eds. Mechanisms of Heart Failure. Boston: Kluwer Academic Publishers, 1995:75-90.
8. Bishop JE, Laurent GJ. Collagen turnover and its regulation in the normal and hypertrophying heart. Eur Heart J 1995;16(Suppl C): 38-44.
9. Iimoto DS, Covell JW, Harper E. Increase in cross-linking of type I and type III collagens associated with volume-overloaded hypertrophy. Cure Res 1988;63:399-408.
10. Weber KT, Brilla CG. Pathological hypertrophy and cardiac mterstitium. Circulation 1991;83:1849-65.
11. Borg T, Johnson LD, Lill PH. Specific attachment of collagen to cardiac myocytes: in-vivo and in-vitro. Dev Biol 1983;97:417-23.
12. Eng C, Zhao M, Factor SM, Sonnenbhck EH. Post-ischemic cardiac dilation and remodeling: reperfusion injury of the interstitium. Eur Heart J 1993;14(Suppl A):27-32.
13. Speiser B, Weihrauch D, Riess CF, Schaper J. The extracellular matrix in human cardiac tissue part II: vimentin, laminin, and fibroneccin. Cardioscience 1992;3:41-9.
14. Casscells W, Kimura H, Sanchez JA, Yu ZX, Ferrans VJ. Immunohistochemical study of fibronectin in experimental myocardial infarction. Am J Pathol 1990;137:801-10.
15. Farhadian F, Contard F, Corbier A, Barrieux A, Rappaport L, Samuel JL. Fibronectin expression during physiology and pathological cardiac growth. J Mol Cell Cardiol 1995;27:981-90.
16. Farhadian F, Barneux A, Lortet S, et al. Differential splicing of fibronectin pre-messenger libonucleic acid during cardiac ontogeny and development of hypertrophy in the rat. Lab Invest 1994;71:552-9.
17. Kreis T, Vale R, eds. Guidebook to the Extracellular Matrix and Adhesion Proteins. London: Oxford University Press, 1993:66.
18. Price RL, Nakagawa M, Terracio L, Borg TK. Ultrastructural localizition of laminin on in vivo embryonic, neonatal, and adult rat cardiac myocytes and in early rat embryos raised in whole-embryo culture. J Histochem Cytochem 1992;40:1373-81.
19. Lundgren E, Gullberg D, Rubin K, Borg TK, Terracio MJ, Terracio L. In vitro studies on adult cardiac myocytes: attachment and biosynthesis of collagen type IV and laminin. J Cell Physiol 1988;136:43-53.
20. Lundgren E, Terracio L, Mardh S, Borg TK. Extracellular matrix components influence the survival of adult cardiac myocytes in vitro. Exp Cell Res 1985;158:371-81.
21. Carey DJ. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol 1991;53:161-77.
22. Matsumura S, Kawazoye S, Tian SF, et al. Organizations of extracellular matrices in aortic and mesenteric arteries of stroke-prone spontaneously hypertensive rat. Ann NY Acad Sci 1995;748:534-7.
23. Keeley FW, Rabinovitch M. Vascular matrix metabolism in hypertension. In: Bishop JE, Laurent GJ, Reeves J, eds. Pulmonary Vascular Remodeling. London: Portland Press Ltd, 1995:149-69.
24. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
25. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinase and cardiovascular disease. Circ Res 1995;77:863-8.
26. Chua CC, Chua BHL, Zhao ZY, Krebs C, Diglio C, Perrin E. Effect of growth factors on collagen metabolism in cultured human heart fibroblasts. Connect Tissue Res 1991;26:271-81.
27. Kerr LD, Miller DB, Matrisian LM. TGF-β1 inhibition of transin/stromelysm gene expression is mediated through a Fos binding sequence. Cell 1990;61:267-78.
28. Overall CM, Wrana JL, Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. J Biol Chem 1991;266:14064-71.
29. Ito KI, Ryuto M, Ushiro S, et al. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on matrigel. J Cell Physiol 1995;162:213-24.
30. Lum ZP, Hakala BE, Mort JS, Recklies AD. Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta. J Cell Physiol 1996;166:351-9.
31. Tyagi SC, Kumar SG, Banks J, Fortson W. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium. J Mol Cell Cardiol 1995;27:2177-89.
32. Tyagi SC, Kumar SG, Glover G. Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endochelial cells. J Cell Biochem 1995;58:360-71.
33. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Circulation 1990;81:1161-72.
34. Takahashi S, Barry AC, Factor SM. Collagen degradation in ischemic rat hearts. Biochem J 1990;265:233-41.
35. Charney RH, Takahashi S, Zhao M, Sonnenblick EH, Eng C. Collagen loss in the stunned myocardium. Circulation 1992;85:1483-90.
36. Sato S, Ashraf M, Millard RW, Fujiwara H, Schwartz A. Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study. J Mol Cell Cardiol 1983;15:261-75.
37. Tyagi SC, Kumar S, Alla SR, Reddy HK, Voelker DJ, Janicki JS. Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells. J Cell Physiol 1996;167:137-47.
38. Przyklenk K, Connelly CM, McLaughlin RJ, Kloner RA, Apstein CS. Effect of myocyte necrosis on strength, strain, and stiffness of isolated myocardial strips. Am Heart J 1987;114:1349-59.
39. Shekhonin BV, Guriev SB, Irgashev SB, Koteliansky VE. Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction. J Mol Cell Cardiol 1990;22:533-41.
40. Knowlton AA, Connelly CM, Romo GM, Mamuya W, Apstein CS, Brecher P. Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. J Clin Invest 1992;89:1060-8.
41. van Krimpen C, Smits JFM, Cleutjens JPM, et al. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 1991;23:1245-53.
42. Pelouch V, Dixon IMC, Sethi R, Dhalla NS. Alteration of collagenous protein profile in congesave heart failure secondary to myocardial infarction. Mol Cell Biochem 1993;129:121-31.
43. McCormick RJ, Musch TI, Bergman BC, Thomas DP. Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats. Am J Physiol 1994;266:H354-9.
44. Reiser JM, McCormick RJ, Rucker RB. The enzymatic and non-enzymatic crosslinking of collagen and elastin. FASEB J 1992;6:2439-49.
45. Schieffer B, Wirger A, Meybrunn M, et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994;89:2273-82.
46. Cleutjens JPM, Verluyten MJA, Smits JFM, Daemen MJAP. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 1995;147:325-38.
47. Schaper J, Speiser B. The extracellular matrix in the failing human heart. Basic Res Cardiol 1992;87(Suppl 1):303-9.
48. Litwin SE, Litwin CM, Raya TE, Warner AL, Goldman S. Contractility and stiffness of noninfarcted myocardium after coronary legation in rats. Circulation 1991;83:1028-37.
49. Zellner JL, Spinale FG, Eble DM, Hewett KW, Crawford FA Jr. Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Circ Res 1991;69:590-600.
50. Brilla CG, Reams GP, Maisch B, Weber KT. Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix. Eur Heart J 1993;14:(Suppl J):57-61.
51. Mindan FJP, Panizo A. Alterations in the extracellular matrix of the myocardium in essential hypertension. Eur Heart J 1993;14 (Suppl J):12-4.
52. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-β1, fibronectin, and collagen. Am J Physiol 1992;262:H1861-6.
53. Chapman D, Weber KT, Eghbali M. Regulation of fibrillar collagen type I and type III and basement membrane type IV. Collagen gene expression in pressure overloaded rat myocardium. Circ Res 1990;67:787-94.
54. Lipke DW, McCarthy KJ, Elton TS, Arcot SS, Oparil S, Couchman JR. Coarction induces alterations in basement membranes in the cardiovascular system. Hypertension 1993;22:743-53.
55. Kim S, Ohta K, Hamaguchi A, et al. Angiotensin type I receptor antagonist inhibits the gene expression of transforming growth factor-β1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther 1995;273:509-15.
56. Botuyt MO, O'Neill L, Meredith AL, et al. Alteration in cardiac gene expression during the transition from stable hypertrophy to heart failure. Circ Res 1994;75:23-32.
57. Conard CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OHL. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995;91:161-70.
58. Doering CW, Jalil JE, Janick JS, et al. Collagen network remodelling and diastohc stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 1988;22:686-95.
59. Panizo A, Pardo J, Hernandez M, Galindo MF, Cenarruzabeitia E, Diez J. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens 1995;8:815-22.
60. Nagasawa K, Zimmermann R, Munkel B, Linz W, Scholkens B, Schaper J. Extracellular matrix deposition in hypertensive hearts: antifibrotic effects of ramipnl. Eur Heart J 1995;16(Suppl C):33-7.
61. Vacher E, Fornes P, Richer C, Bruneval P, Nisato D, Giudicelli JF. Early and late hemodynamic and morphological effects of angiotensin II subtype 1 receptor blockade during genetic hypertension development. J Hypertens 1995;13:675-82.
62. Bruckschlegel G, Holmer SR, Jandeleit K, et al. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 1995;25:250-9.
63. Hermans WRM, Rensing BJ, Strauss BH, et al. Ptevention of restenosis after percutaneous transluminal coronary angioplasty (PTCA): the search for a 'magic bullet'. Am Heart J 1991;122:171-87.
64. Muller DWM, Ellis SG, Topol EJ. Experimental models of coronary artery restenosis. J Am Coll Cardiol 1992;19:418-32.
65. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-8.
66. Macleod DC, Struss BH, de Jong M, et al. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. J Am Coll Cardiol 1994;23:59-65.
67. Riessen R, Isner JM, Blessing E, Loshin C, Nikol S, Wight TN. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 1994;144:962-74.
68. Riessen R, Wight TN, Pastore C, Henley C, Isner JM. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 1996;93:1141-7.
69. Kim S, Kawamura M, Wanibuchi H, et al. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation 1995;92:88-95.
70. Huckle WR, Drag MD, Acker WR, et al. Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis. Circulation 1996;93:1009-19.
71. Pratt RE, Dzau VJ. Pharmacological strategies to prevent restenosis. Lessons learned from blockade of the renin-angiotensin system. Circulation 1996;93:848-52.
72. Wysoki SJ, Zheng MH, Fan Y, Lamawansa MD, House AK, Norman PE. Expression of transforming growth factor-β1 (TGF-β1) and urokinase-type plasminogen activator (u-PA) genes during arterial repair in the pig. Cardiovasc Res 1996;31:28-36.
73. Rasmussen LM, Wolf YG, Ruoslahti E. Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-β activity. Am J Pathol 1995;147:1041-8.
74. Nabel EG, Shum L, Pompili VJ, et al. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 1993;90:10759-63.
75. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994;75;539-45.
76. Newby AC, Southgate KM, Davies M. Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis. Basic Res Cardiol 1994;89(Suppl 1)59-70.
77. Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ. Proteinases and restenosis in the human coronary artery: extracellular production exceeds the expression of proteolytic activity. Atherosclerosis 1995;116:43-57.
78. Majesky MW. Neointima formation after acute vascular injury: role of conteradhesive and extracellular matrix proteins. Tex Heart Inst J 1994;21:78-85.